Latest Health & Nutrition News and Videos
Anavex Life Sciences withdrew its application for
Insilico Medicine announced a drug discovery coll
Allergan Aesthetics, an AbbVie company, presented
Aubrey De Grey breaks down longevity escape velo
Longevity biotech investment in 2026 is no longe
Researchers use AI to redesign antibody fragment
At AMWC Monaco, Allergan Aesthetics says the fut
New research shows that type 2 diabetes and wors
Alterity Therapeutics received positive feedback
With just weeks to go, the longevity industry’
With just weeks to go, the UK’s defining event
New Longevity Show blog explores how clinics are
New partnership brings early cognitive screening
Coordinated demonstrations across 14 cities set
$2.
Allergan Aesthetics, an AbbVie company, positione
Insilico Medicine and Tenacia Biotechnology are e
BCC Research has published a Pulse research title
Research projects the global cell therapy manufac
Phase 1 data suggest senotherapeutic activity in
Novo Nordisk’s higher-dose semaglutide arrives
Human Longevity and LEV Foundation will study ce
Cellbricks Therapeutics has raised €10 million
Alina M Hernandez and Nigel Franklyn on why long
Maze Therapeutics announced positive topline Phas
Human Longevity, Inc.
Rubedo Life Sciences reported preliminary Phase 1
Fresh funding backs a high-stakes attempt to do
SEMCAP is betting that longevity’s next growth
Immortal Dragons-backed Unlimited Bio registers
New data link popular weight-loss drugs to highe
Deal worth up to $150m comes as supplementation
20/20 BioLabs has entered an exclusive U.S.
20/20 BioLabs has entered an exclusive U.S.
Anavex Life Sciences withdrew its marketing autho
Cognito Therapeutics and Ochsner Health have laun
SpectraCell Laboratories introduced Baseline Nexu
Roatán-based longevity clinic adds Klotho to it
Combined company targets mitochondrial biology a
Cognito and Ochsner join forces to explore how c
As longevity biotech scales, new AI tools target
Fresh Alzheimer’s theory gives investors new l
New profiling tech looks beyond which microbes l
Longevity Medical Institute’s new paper adds w
Celosia Therapeutics announced on 23 March 2026,
C2N Diagnostics reported the first application of
Nanoscope Therapeutics announced publication of a
Annovis has partnered with NeuroRPM to deploy an
Alnylam is launching coordinated initiatives to a
Preprint RCT in healthy adults suggests multi-ta